Wakefulness is driven by the widespread release of neuromodulators by the ascending arousal system. Yet, it is unclear how these substances orchestrate state-dependent, global changes in neuronal activity. Here W akefulness and sleep represent two fundamentally different behavioral states (1). While awake, we are responsive to our surroundings, integrate sensory input, recall memories, and make decisions, whereas contact with the outside world is limited during sleep. These two states of brain activity show characteristic patterns of cortical electroencephalography (EEG), gene expression, and metabolic signature (2, 3). The concerted release of neuromodulators-including norepinephrine, acetylcholine, histamine, dopamine, and orexin-mediates arousal (4). All of these neuromodulators individually alter the membrane properties, spiking activity, and intracellular signaling pathways of subpopulations of neurons and glia (5), but how they implement the striking stereotypic patterns of EEG activity characterizing wakefulness versus sleep is not understood (6).
. While awake, we are responsive to our surroundings, integrate sensory input, recall memories, and make decisions, whereas contact with the outside world is limited during sleep. These two states of brain activity show characteristic patterns of cortical electroencephalography (EEG), gene expression, and metabolic signature (2, 3) . The concerted release of neuromodulators-including norepinephrine, acetylcholine, histamine, dopamine, and orexin-mediates arousal (4) . All of these neuromodulators individually alter the membrane properties, spiking activity, and intracellular signaling pathways of subpopulations of neurons and glia (5) , but how they implement the striking stereotypic patterns of EEG activity characterizing wakefulness versus sleep is not understood (6) .
Neuronal excitability can be modulated by changes in the composition of extracellular ions. For example, moderate elevations of [K + ] in the bath solution (1 to 2 mM) increase spontaneous and evoked excitatory activity in hippocampal slices, and more robust elevations (2 to 5 mM) trigger seizure-like activity (7) . Lowering extra- ] e ) also potently alters excitability (7) .
Neuromodulators increase extracellular K + independently of synaptic activity
It is not known whether the changes in extracellular ion concentrations that occur during the natural sleep-wake cycle (8) are primary or secondary to alterations in electrical activity. In fact, the changes in extracellular ions that accompany behavioral states would be considered by most to be a consequence of different patterns of neuronal activity. However, ion transport is regulated by catecholamines outside the central nervous system (CNS) (5 Wakefulness triggers an increase in extracellular K + that is independent of AMPA receptors
We next measured state-dependent changes in extracellular ion concentrations in vivo ( fig. S2A ). All recordings were collected between zeitgeber times (ZT) 4 and 8 (ZT times are based on a 24-hour diurnal cycle standardized so that ZT0 is the beginning of the sleep period and ZT12 is the beginning of the awake period). Sleep was defined as periods with high electrocorticography (ECoG) delta activity and low electromyography (EMG) activity relative to periods when animals were awake. Starting from sleep, [K + ] e rose rapidly by 0.40 ± 0.05 mM (Fig. 2, A and B) as animals awoke, before returning to baseline as animals fell back asleep. These transitions occurred quickly, with increases peaking within 1.3 ± 0.02 s (range 0.1 to 8.6 s, n = 27 transitions), whereas the transition back to sleep was substantially slower and more variable, 13.9 ± 2.7 s [range 1.8 to 45.9 s, t(55) = 3.22, P = 0.002].
We next investigated the effect of isoflurane anesthesia on [K + ] e and collected recordings during the animals' natural wake period (ZT16 to ZT20). After obtaining a stable awake [K + ] e baseline, 2% isoflurane was administered, which consistently triggered a sharp decrease in [K + ] e of 0.37 ± 0.06 mM (Fig. 2C ). This decrease in [K + ] e remained stable throughout isoflurane administration and recovered to pre-anesthesia awake levels over 148 ± 41 s after cessation of anesthesia (n = 9 animals). Both the shift into and recovery from anesthesia mirrored changes in ECoG and EMG activity (Fig. 2C) .
To critically evaluate the stability of statedependent ion shifts, microdialysis samples of the extracellular fluid were collected in freely behaving, unrestrained mice. We used the no-net flux paradigm to estimate [ ] e consistently decreased 0.13 ± 0.02 mM as mice transitioned from sleep to awake states and, conversely, increased by 0.11 ± 0.01 mM as the mice returned to sleep (Fig. 3, A 4C ) before gradually returning to baseline over 26.7 ± 5.7 min (9.6 to 66.3 min, n = 9 animals) after the cessation of anesthesia.
Microdialysis samples were collected during the sleep (ZT2 to ZT8) and awake (ZT14 to ZT20) periods and were pooled and compared with isoflurane-induced shifts in [Mg 2+ ] e , demonstrating an increase of 0.32 ± 0.13 mM [Mg 2+ ] e in isoflurane samples (Fig. 4D) . CNQX neither altered basal [Mg 2+ ] e nor the previously observed isofluraneinduced increase in [Mg 2+ ] e (Fig. 4E) . Thus, across all experiments [Mg 2+ ] e increased as mice went from awake to sleep or isoflurane (Fig. 4E) .
Robust changes in pH were also noted with isoflurane anesthesia. Recordings with pH-sensitive microelectrodes showed that pH decreased from an awake level of 7.39 ± 0.03 to a stable isofluraneanesthetized level of 7.26 ± 0.02 ( fig. S3 ). fig. S4, B and D) . It was not possible to produce pH shifts of the magnitude seen in awake-to-isoflurane transitions with moderate changes in ACSF pH (∼1 pH), likely reflecting the efficacy by which CO 2 /HCO 3 -system buffer pH ( fig. S4, B and D) ] e shifts from the awake-to-sleep, isoflurane, CNQX, and CNQX + isoflurane. n = 8 animals; CNQX and CNQX + isoflurane oneway ANOVA comparison of state-dependent shifts, F(4,117) = 5.824, P = 0.0003; Post-hoc Tukey test, *P < 0.05, **P < 0.01. Mean (black circle) ± SEM.
Local manipulation of extracellular ions
Can local manipulation of extracellular ions in itself drive sleep-or awake-like patterns of neuronal activity? We prepared mice with two separate cranial windows located over the left and right hemisphere and recorded ECoG symmetrically from each (Fig. 5A) . Starting in sleeping mice (ZT4 to ZT8) with sleep ACSF (table S1) over each window, recordings were collected from each hemisphere. After this baseline period, the ACSF over the left window was removed and replaced with awake-inducing ACSF. When activity in the left hemisphere was normalized to the right in order to preclude changes from global state transitions, we observed a 34 ± 5% decrease in 1-to 4-Hz ECoG power after application of awake-inducing ACSF, with no change in activity in the contralateral hemisphere (Fig. 5B) . In comparison, natural sleep-to-wake transitions decrease the 1-to 4-Hz power by 31.1 ± 3.1% (mean ± SEM of all data, n = 128 transitions). Conversely, could sleep-inducing ACSF increase local delta power in awake mice? Recording between ZT16 and ZT20, awake mice were prepared with awake ACSF covering each cranial window. After a baseline recording, the ACSF over the left hemisphere was replaced with sleep-inducing ACSF, resulting in a 43 ± 13% relative increase in 1-to 4-Hz delta power in the left hemisphere exposed to the sleep-inducing ACSF (Fig. 5C) .
Because state-dependent changes in brain activity are also linked to marked changes in the extracellular space volume (10), we asked whether altering the local ion composition can drive extracellular space volume changes. Tetramethylammonium (TMA + ) recordings showed that in lightly anesthetized mice (1% isoflurane administered so as to avoid arousal episodes), changing ACSF from sleep ACSF to awake-inducing induced a 21.7 ± 1.2% decrease in the local extracellular space volume (Fig. 5D) . Tortuosity (l) was consistent with previous studies (11) . Conversely, the extracellular space volume increased by 32.2 ± 2.9% from baseline recordings obtained with awake ACSF to those recorded by using sleep-inducing ACSF in awake mice, despite mice remaining awake and mobile, with tortuosity remaining unchanged (Fig. 5D ).
Brain-wide manipulations of extracellular ions can override behavioral states
Would global manipulation of the extracellular ion composition be sufficient to change the behavioral state of mice? We implanted EEG and EMG electrodes, as well as a cannula in cisterna magna (10) . In sleeping mice (ZT4), a baseline recording was acquired by infusing sleep ACSF followed by a switch to a modified awake-inducing ACSF (Fig. 5E ). This switch triggered a robust change in EEG/EMG activity (Fig. 5E) , with decreased EEG amplitude and delta prevalence and increased EMG activity, indicative of an awake-phenotype. Infusion rates were comparable with CSF production, and ion concentrations were chosen to account for total brain and CSF volume (supplementary materials, materials and methods). Typically, ACSF infusion itself did not alter EEG activity ( fig. S5, A and B) . Mice returned to sleep shortly after discontinuation of awake-inducing ACSF infusion (Fig. 5F ). We next tested whether infusion of a modified sleepinducing ACSF could alter the behavioral state of mice during their awake-period. Baseline EEG/EMG activity characteristic of awake mice was recorded while infusing awake ACSF followed by a modified sleep-inducing ACSF. Infusion induced a sharp reduction in EMG activity coupled to a marked increase in slow-wave EEG activity, indicating a shift toward sleep. EEG/EMG activity typical of wakefulness rapidly recovered upon stopping infusion of the modified sleepinducing ACSF (Fig. 5G) .
Discussion
Understanding what drives arousal is essential for deciphering key aspects of consciousness and the lack thereof during sleep and anesthesia. We found that the transition from wakefulness to sleep is accompanied by a marked and sustained change in the concentration of key extracellular ions and the volume of the extracellular space. Arousal triggers a rapid rise in [ ] e is given to the left of the ISM trace. n = 73 sleep-to-awake transitions (A) and 58 awake-to-sleep transitions (B). One-way ANOVA, F(3, 258) = 28.13, P < 0.0001. Posthoc Tukey test, ***P < 0.001. Scale bars, x = 20 s, y = 0.05 mM [Mg 2+ ] e , 0.33 mV EMG/ECoG. (C) Representative awake-to-isoflurane recording (ZT16 to ZT20) and summary of changes. n = 11 animals. One-way repeated measures ANOVA, F(2,20) = 28.13, P < 0.0001. Post-hoc Tukey test, *P < 0.05, ***P < 0.001. Scale bar, ] e shifts from awake-to-sleep, isoflurane, CNQX, and awake + CNQX to isoflurane + CNQX. n = 6 awake-to-CNQX animals and 6 awake + CNQX-to-isoflurane + CNQX animals. One-way ANOVA of relative state-dependent shifts, F(4,167) = 27.31, P < 0.0001. Post-hoc Tukey test, **P < 0.01, ***P < 0.001. Mean (black circle) ± SEM.
widespread cortical areas because the samples were collected by 2-mm-long probes.
All ions exhibited far more consistent, rapid transitions during arousal relative to falling asleep. This is consistent with the need to quickly shift from sleep to awake states when presented with novel, threatening, or unexpected stimuli, and with the overarching ability of brainstem neuromodulatory centers to drive near-immediate responses to behaviorally relevant events (12 ] e relieves the depolarization block of the N-methyl-D-aspartate (NMDA) receptors and facilitates induction of long-term potentiation (LTP) and, in more extreme cases, seizure (7, 16) . Wakefulness and sleep deprivation are linked to up-regulation of pathways downstream of NMDA receptor activation, including CamKII, extracellular signalregulated kinase (ERK), and pCreb (1, 17 ] e increases during sleep is consistent with the observation that changes in dietary magnesium can have a profound impact on learning and memory, possibly by improving both the amount and quality of sleep (18, 19) .
Arousal is triggered by the concerted activity of neurons located in the brainstem, hypothalamus, and basal forebrain (1, 4) . Projections from these clusters of neurons release norepinephrine, acetylcholine, orexin, serotonin, dopamine, and histamine over widespread areas of the CNS (12) . Considerable redundancy exists in the system; acute antagonism, ablation, or activation has documented the importance of the individual components in regulating arousal, but such perturbations rarely produce long-term effects (12) . An unanswered question is how these neuromodulators drive global changes in EEG activity. Conventional thinking is that the neuromodulators alter the membrane properties and spiking activity of select subtypes of neurons (5 (Fig. 2E and fig. S2 ). This response to an external challenge suggests that ionic homeostasis is tightly regulated in a state-dependent, neuronal activity-independent manner. On the basis of this, we propose that the neuromodulatorsin addition to their well-documented, direct effect on neuronal activity-maintain sleep and awake states by creating a state-dependent setpoint for interstitial ion concentrations that stabilize over seconds to minutes, minimizing changes that result from transient burst firing or suppression of these brainstem nuclei. surface-charge screening and inactivation of the NALCN channel-dependent Na + -leak current (20 (21) (22) (23) and is strongly inhibited by anesthesia (24) .These observations suggest that regulation of extracellular ion homeostasis is sufficient to alter behavioral state both locally and globally, providing a path for neuromodulators to exert consistent, stable shifts in neuronal and astrocytic activity across the brain.
A myriad of electrophysiological slice studies have in the past taken advantage of minor modifications in the ion composition of the bath solution to induce stable and highly reproducible changes in neural excitability. The observations presented here suggest that the CNS itself uses the same trick to control state-dependent changes in neuronal activity. One advantage of this "ionostatic control" of neural activity is to provide a backdrop for coordinating shifts in behavioral state through the widespread regulation of excitability without relying on complex receptor activation in diverse subclasses of neurons. The characteristic state-dependent pattern of EEG activity can, at least in part, be explained by differences in extracellular ion composition in sleep versus wakefulness. Our observations add new and critical insight into understanding what drives arousal, as well as the loss of consciousness during sleep and anesthesia. Future studies should define whether changes in extracellular ion concentrations are involved in disorders such as stupor and coma.
